Clinical Medicine Insights-Blood Disorders

作者需在提交过程中列出每位作者的贡献，并在提交中包含作者贡献标题（位于致谢部分之后），提交时提供的信息将在校对阶段显示在作者贡献标题下。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

该期刊致力于促进研究的开放性、透明度和可重复性，在符合伦理和法律考虑的前提下，鼓励作者在相关公共数据存储库中共享研究数据，并包含链接到数据的数据可用性声明，如果无法共享数据，则使用声明确认原因，并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

作者需在伦理考虑标题下包含伦理批准声明，即使已在方法部分包含伦理批准信息；如果不需要伦理批准，需明确说明；报告涉及人类参与者、人类数据或人体组织研究的论文必须声明相关伦理委员会或机构审查委员会批准了研究，或豁免了批准要求，并提供审查委员会的全名和机构以及批准号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. You can find information on what to say in your ethical statements as well as example statements on our Publication ethics and research integrity policies page. All papers r…

该期刊为开放获取期刊，接受的文章在发表后立即免费在线提供，采用知识共享许可协议，永久在线托管；同行评审后接受发表时需支付一次性文章处理费（APC），由资助者、机构或作者支付，提交稿件不收费，APC目前为1600美元，在同行评审后接受发表时、发表前支付，APC在适用情况下需缴税。 模型中文摘要

Blood & Plasma is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by the funder, in…

该期刊采用单盲同行评审流程，审稿人与编辑互动，不公布评审信息；稿件首先进行初步评估，不符合指南要求的稿件将被退回修改，超出范围或不合适的稿件可能被直接拒稿，通过初步评估后进行同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single Anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

该期刊和Sage非常重视版权侵权、抄袭或其他违反出版最佳实践的问题，请阅读Sage关于抄袭的完整政策以及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊考虑已在预印本服务器上发布的稿件，提交时需在指定字段中输入预印本DOI，建议在提交时告知期刊编辑部已发布的预印本，在同行评审期间不应在预印本服务器上发布更新版本的稿件。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

该期刊遵循ICMJE要求，临床试验在首次参与者入组时或之前在WHO批准的公共试验注册中心注册作为考虑发表的条件，试验注册中心名称和URL以及注册号必须包含在摘要末尾。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.